期刊文献+

激素替代治疗对绝经后子宫肌瘤患者的影响分析 被引量:4

Effect of hormone replacement therapy on the uterine structure for patients with myoma of uterus in postmenopause
原文传递
导出
摘要 目的 探讨激素替代治疗对绝经后子宫肌瘤患者的影响.方法 选取确诊绝经后期的子宫肌瘤患者80例,采用随机双盲法分为研究组43例(给予激素替代治疗,小剂量雌二醇联合地屈孕酮)和对照组37例(给予谷维素治疗).比较治疗12个月后两组激素水平(卵泡刺激素、黄体生成素)、子宫结构(子宫肌瘤体积、子宫内膜厚度、子宫体积).结果 在患者激素水平方面,研究组患者黄体生成素(12.19±2.39)U/L,卵泡刺激素(13.14±5.29)U/L;对照组患者黄体生成素(15.09±3.18)U/L,卵泡刺激素(22.19±6.25)U/L,研究组较对照组均明显降低(t=11.312、10.583,均P〈0.05).在患者子宫结构方面,研究组患者子宫肌瘤体积(6.45±2.21)cm3,子宫体积(45.56±15.17)cm3,子宫内膜厚度(2.84±1.07)mm;对照组患者子宫肌瘤体积(5.92±1.81)cm3,子宫体积(38.25±10.52)cm3,子宫内膜厚度(2.36±0.82)mm,研究组较对照组子宫肌瘤体积无明显增加,差异无统计学意义(t=1.043,P〉0.05),子宫体积及子宫内膜厚度略增加,差异均有统计学意义(t=8.492、7.954,均P〈0.05).结论 在绝经后子宫肌瘤患者子宫功能结构方面,激素替代治疗可改善子宫结构功能,并且不增大子宫肌瘤,同时降低卵泡刺激素、黄体生成素水平. Objective To investigate the effect of hormone replacement therapy on the uterine structure for patients with myoma of uterus in postmenopause. Methods According to the method of treatment, 149 patients were divided into study group ( 73 cases) and control group ( 76 cases ). The control group was given oryzanol, while the study group was given hormone replacement threapy ( little dose of estradiol combined with dydrogesterone). The sex hormone levels( LH, FSH),uterine structure( volume of uterine fibroids, endometrial thickness, uterine volume) were compared. Results The sex hormone levels of LH, FSH in the study group were ( 12.19 ±2.39 ) U/L, ( 13.14 ± 5.29 )U/L, respectively, which were lower than those in the control group [ (15.09 ± 3.18 )U/L, (22.19 ±6.25 )U/L ] , the differences were statistically significant ( t = 11.312,10. 583, all P 〈 0.05 ). The volume of uterus fibroids, volume of uterine,endometrial thickness in the study group were (6.45 ± 2.21 ) cm3, (45. 56 ± 24. 17) cm3, (2. 84± 1.07) mm,respectively, which in the control group were ( 5.92 ± 2. 31 ) cm3, ( 38. 25 ± 20. 52 ) cm3, ( 2. 36 ± 0.82)ram, respectively. Compared with the control group, the study group had bigger uterine and endometrial thickness, the differences were statistically significant ( t = 8. 492,7. 954, all P 〈 0.05 ), while the volume of uterus uteroids had no statistically significant difference between the two groups ( t = 1. 043, P 〉 0.05 ). Conclusion On the uretine structure of patients with myoma of uterus in postmenopause, compared with traditional oryzanol, hormone replacement can improve the status of uretus structure and function, and resist the side - effect of enlargement of the volume of uretus fibroids. There is significant advance for hormone replacement therapy on the uterine structure of patients with uretus fibroids in postmenopause.
作者 谷雨枫 Gu Yufeng.(Department of Genecology, Jiaxing Hospital of Zhengjiang Armed Police Hospital, Jiaxing, Zhejiang 314001, China)
出处 《中国基层医药》 CAS 2018年第9期1134-1137,共4页 Chinese Journal of Primary Medicine and Pharmacy
关键词 绝经后期 激素替代疗法 平滑肌瘤 Postmenopause Hormone replacement therapy Leiomyoma
  • 相关文献

参考文献6

二级参考文献40

  • 1周清,杨孝军,郑飞云.桂枝茯苓胶囊配伍米非司酮治疗子宫肌瘤的Meta分析[J].中国全科医学,2013,16(8):911-915. 被引量:74
  • 2Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women[ J]. Ann Intern Med,1992,117(12) :1016-1037.
  • 3Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus pregestin in healthy postmenopausal women : prin- cipal results From the Women~ Health Initiative randomized con- trolled trial[ J ]. JAMA,2002,288 ( 3 ) :321-333.
  • 4Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease [ J 1. N Engl J Med, 2003,349 (6) :523-534.
  • 5Gurney EP, Nachtigall M J, Naehtigall LE, et al. The Women "s Health Initiative trial and related studies: 10 years later: a clini- cian~ view [ J ]. J Steroid Biochem Mol Biol, 2014, 142 : 4-11. DOI : 10. 1016/j. jsbmb. 2013.10. 009.
  • 6Panay N, Fenton A. A global consensus statement on menopause hormone therapy--aims,aspirations and action points[ J]. Climac- teric,2013,16 ( 2 ) : 201-202. DOI : 10. 3109/13697137. 2013. 772794.
  • 7Saver BG, Taylor TR, Woods NF. Use of hormone replacement therapy in Washington State:is prevention being put into practice [ J ]. J Fam Pract, 1999,48 (5) :364-371.
  • 8俞海燕.性激素替代治疗对围绝经期子宫肌瘤的影响[J].中国初级卫生保健,2009,23(3):84-85. 被引量:3
  • 9陆亦琼,汤振宇,许薇,蒲煜琴,陈倩珊,唐小晴,严凤.某社区妇女围绝经期症状及保健需求调查[J].上海预防医学,2010,22(6):314-316. 被引量:7
  • 10王红菊,张小丽.不同术式对子宫肌瘤患者内分泌生理的影响[J].中国实用医药,2010,5(23):111-114. 被引量:24

共引文献25

同被引文献17

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部